Jishi Wang

Nrf2 overexpression increases risk of high tumor mutation burden in acute myeloid leukemia by inhibiting MSH2

Ping Liu, Dan Ma, Ping Wang et al. · Cell Death and Disease · 2021 · 42 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China

Jianqiu Wu, Yongping Song, Liping Su et al. · Chinese Medical Journal · 2018 · 27 citations · Full text

Medicine, Hematology, Oncology +16

Betulinic acid restores imatinib sensitivity in BCR‐ABL1 kinase−independent, imatinib‐resistant chronic myeloid leukemia by increasing HDAC3 ubiquitination and degradation

Tingting Lu, Danna Wei, Kunlin Yu et al. · Annals of the New York Academy of Sciences · 2020 · 19 citations

Medicine, Oncology, Pharmacology +9

PIM inhibitor SMI-4a induces cell apoptosis in B-cell acute lymphocytic leukemia cells via the HO-1-mediated JAK2/STAT3 pathway

Xingyi Kuang, Jie Xiong, Weili Wang et al. · Life Sciences · 2019 · 15 citations

Life Sciences, Oncology, Pharmacology +8

Updated Efficacy and Safety Results of Lisaftoclax (APG-2575) in Patients (Pts) with Heavily Pretreated Chronic Lymphocytic Leukemia (CLL): Pooled Analyses of Two Clinical Trials

Keshu Zhou, Mingyuan Sun, Wei Xu et al. · Blood · 2023 · 13 citations

Medicine, Oncology, Pharmacology +15